Pulmonary Medicine

Episodes 1-16 of 80

• 

  RestartResume

  Pulmonary Hypertension for Advanced Practice Providers: Risk Stratification and Diagnosis to Enhance Quality of Care and Outcomes

  RestartResume

  Pulmonary Hypertension for Advanced Practice Providers: Risk Stratification and Diagnosis to Enhance Quality of Care and Outcomes

  CME/CE Live Broadcast

  Pulmonary Hypertension for Advanced Practice Providers: Risk Stratification and Diagnosis to Enhance Quality of Care and Outcomes

  September 10, 2024

  01:00 PM - 02:00 PM EDT

  1.00 credit Learn more

• 

  RestartResume

  Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates

  RestartResume

  Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates

  CME/CE Live Broadcast

  Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates

  September 12, 2024

  01:00 PM - 02:00 PM EDT

  1.00 credit Learn more

• 

  RestartResume

  Pulmonary Hypertension Management: Practice Trends and Updates 

  RestartResume

  Pulmonary Hypertension Management: Practice Trends and Updates 

  CME/CE Live Broadcast

  Pulmonary Hypertension Management: Practice Trends and Updates 

  September 24, 2024

  02:00 PM - 03:00 PM EDT

  1.00 credit Learn more

• 

  MinuteCE®

  The Next Generation of Treatment for Patients With PH

  1.00 credit 4 episodes

  • 

    

    Richard N. Channick, MD

  • 

    

    Vallerie V. McLaughlin, MD

  • 

    

    Ioana Preston, MD

  1.00 credit 4 episodes

• 

  RestartResume

  Are the current guidelines current?

  RestartResume

  Are the current guidelines current?

  MinuteCE®

  Are the current guidelines current?

  1.00 program credit

  • 

    

    Vallerie V. McLaughlin, MD

  1.00 program credit

• 

  RestartResume

  Risk and How Risk Directs Treatment: Challenges and Barriers to Risk Stratification

  RestartResume

  Risk and How Risk Directs Treatment: Challenges and Barriers to Risk Stratification

  MinuteCE®

  Risk and How Risk Directs Treatment: Challenges and Barriers to Risk Stratification

  1.00 program credit

  • 

    

    Ioana Preston, MD

  1.00 program credit

• 

  RestartResume

  Risk Stratification Refinements with inclusion of Hemodynamic variables at follow up in patients with PH  

  RestartResume

  Risk Stratification Refinements with inclusion of Hemodynamic variables at follow up in patients with PH  

  MinuteCE®

  Risk Stratification Refinements with inclusion of Hemodynamic variables at follow up in patients with PH  

  1.00 program credit

  • 

    

    Richard N. Channick, MD

  1.00 program credit

• 

  RestartResume

  Strategies to Implement Risk Stratification in the PH Clinic

  RestartResume

  Strategies to Implement Risk Stratification in the PH Clinic

  MinuteCE®

  Strategies to Implement Risk Stratification in the PH Clinic

  1.00 program credit

  • 

    

    Vallerie V. McLaughlin, MD

  • 

    

    Ioana Preston, MD

  1.00 program credit

• 

  RestartResume

  The Promise of Sotatercept in PAH

  RestartResume

  The Promise of Sotatercept in PAH

  MinuteCE®

  The Promise of Sotatercept in PAH

  1.00 program credit

  • 

    

    Ioana Preston, MD

  1.00 program credit

• 

  RestartResume

  Risk stratification refinements with inclusion of hemodynamic variables at follow-up in patients with pulmonary arterial hypertension

  RestartResume

  Risk stratification refinements with inclusion of hemodynamic variables at follow-up in patients with pulmonary arterial hypertension

  MinuteCE®

  Risk stratification refinements with inclusion of hemodynamic variables at follow-up in patients with pulmonary arterial hypertension

  1.00 program credit

  • 

    

    Vallerie V. McLaughlin, MD

  1.00 program credit

• 

  MinuteCE®

  Applying the Latest Evidence in PH Clinical Practice

  1.00 credit 3 episodes

  • 

    

    Richard N. Channick, MD

  • 

    

    Vallerie V. McLaughlin, MD

  • 

    

    Ioana Preston, MD

  1.00 credit 3 episodes

• 

  RestartResume

  Macitentan Update: Impact on Management of Pulmonary Hypertension

  RestartResume

  Macitentan Update: Impact on Management of Pulmonary Hypertension

  MinuteCE®

  Macitentan Update: Impact on Management of Pulmonary Hypertension

  1.00 program credit

  • 

    

    Richard N. Channick, MD

  1.00 program credit

• 

  RestartResume

  Practical Implications of New Treatments in Clinical Practice

  RestartResume

  Practical Implications of New Treatments in Clinical Practice

  MinuteCE®

  Practical Implications of New Treatments in Clinical Practice

  1.00 program credit

  • 

    

    Jean M. Elwing, MD

  • 

    

    Richard N. Channick, MD

  • 

    

    Victor Moles, MD

  1.00 program credit

• 

  RestartResume

  Don’t Wait to Escalate—Getting Aggressive in PH Management

  RestartResume

  Don’t Wait to Escalate—Getting Aggressive in PH Management

  MinuteCE®

  Don’t Wait to Escalate—Getting Aggressive in PH Management

  1.00 program credit

  • 

    

    Jean M. Elwing, MD

  1.00 program credit

• 

  RestartResume

  Finding the Patient With PH Among Us: How We Optimize Treatment Based on Patient Type

  RestartResume

  Finding the Patient With PH Among Us: How We Optimize Treatment Based on Patient Type

  MinuteCE®

  Finding the Patient With PH Among Us: How We Optimize Treatment Based on Patient Type

  1.00 program credit

  • 

    

    Richard N. Channick, MD

  1.00 program credit

• 

  MinuteCE®

  The Next Generation of Risk Stratification in Patients With PH

  1.00 credit 4 episodes

  • 

    

    Jean M. Elwing, MD

  • 

    

    Richard N. Channick, MD

  • 

    

    Victor Moles, MD

  1.00 credit 4 episodes